Judge Rules Allergan's Sanctura XR Patents Invalid
Allergan Inc. suffered a blow on Saturday when a Delaware federal judge ruled three patents covering the drugmaker's overactive bladder drug Sanctura XR were invalid, finding prior art rendered the patents'...To view the full article, register now.
Already a subscriber? Click here to view full article